Assenagon Asset Management’s Ovid Therapeutics OVID Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Sell |
435,620
-125,210
| -22% | -$41.3K | ﹤0.01% | 1102 |
|
|
2025
Q1 | $175K | Buy |
560,830
+490,716
| +700% | +$153K | ﹤0.01% | 1098 |
|
|
2024
Q4 | $65.5K | Sell |
70,114
-16,175
| -19% | -$15.1K | ﹤0.01% | 1275 |
|
|
2024
Q3 | $102K | Buy |
+86,289
| New | +$102K | ﹤0.01% | 1305 |
|
|
2024
Q2 | – | Sell |
-114,265
| Closed | -$349K | – | 1432 |
|
|
2024
Q1 | $349K | Buy |
114,265
+35,786
| +46% | +$109K | ﹤0.01% | 1229 |
|
|
2023
Q4 | $253K | Buy |
+78,479
| New | +$253K | ﹤0.01% | 1298 |
|
|
2022
Q3 | – | Sell |
-26,362
| Closed | -$57K | – | 1448 |
|
|
2022
Q2 | $57K | Buy |
+26,362
| New | +$57K | ﹤0.01% | 1375 |
|
|
2021
Q4 | – | Sell |
-334,589
| Closed | -$1.12M | – | 1474 |
|
|
2021
Q3 | $1.12M | Buy |
+334,589
| New | +$1.12M | ﹤0.01% | 834 |
|
|
2020
Q3 | – | Sell |
-510,302
| Closed | -$3.76M | – | 1259 |
|
|
2020
Q2 | $3.76M | Buy |
510,302
+390,242
| +325% | +$2.88M | 0.02% | 382 |
|
|
2020
Q1 | $358K | Buy |
120,060
+54,154
| +82% | +$161K | ﹤0.01% | 652 |
|
|
2019
Q4 | $274K | Buy |
+65,906
| New | +$274K | ﹤0.01% | 666 |
|